Global Venturing Review

The Big News It’s been a good week for healthcare flotations, with Revolution Medicines following in the footsteps of successful IPO closures by Schrödinger and Beam Therapeutics by going public in a $238m offering that represented an increase in size of almost 50% from when it first set the range earlier this month. The precision oncology therapy … Continue reading "17 February 2020 – Revolution Medicines Goes Public in $238m Offering"